HIAA, PhRMA Will "Mend" Relationship After Medicare Rx Dispute - Kahn
Executive Summary
The Health Insurance Association of America and the Pharmaceutical Research & Manufacturers of America will be able to overcome differences that emerged during the Medicare drug benefit debate, HIAA President Chip Kahn predicted in an Oct. 30 address to the insurance association annual meeting in Las Vegas.
You may also be interested in...
Drug Companies, Insurers Can Agree On Broad Medicare Reforms, Lilly Says
Pharmaceutical manufacturers and health insurance companies can agree on broad Medicare reforms and the long-term objective of incorporating drug coverage into an integrated senior benefit, Lilly Chairman Sidney Taurel told a National Press Club luncheon in Washington, D.C. Jan. 18.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011